mdl 1

(Z)-MDL 105519是 MDL105519 无活性的异构体。

MDL 100009 是 MDL 100151 的 S-对映体和 MDL 100907 的相反对映体，是 5-HT2A 的选择性拮抗剂。

MDL 19301 is a nonsteroidal, anti-inflammatory agent.

MDL 100748 is a glycine site antagonist of NMDA receptor.

MDL 101146 is an orally active neutrophil elastase inhibitor.

MDL 105519 is an effective antagonist of glycine binding to the NMDA receptor.

MDL-19744A is an alpha 1-adrenergic receptor antagonist and renal vasodilator.

MDL-105212A HCl is a nonpeptide NK-1 and NK-2 receptor antagonist.

MDL-100240 is a dual inhibitor of angiotensin-converting enzyme (ACE) and neprilysin with a balanced activity. MDL 100240 shows an impressive effectiveness both in preventing and in regressing hypertension-induced vascular remodeling and cardiac hypertrop

MDL-100173 is a dual angiotensin-converting enzyme (ACE) neutral endopeptidase (NEP) inhibitor.

KAA-276 free base is a novel potent and long-lasting histamine HI-receptor antagonist with less-topical irritation, and can be topically administered by inhalation for the treatment of bronchial asthma.

MMG-0358 is a novel potent IDO1 inhibitor, showing low cytotoxicity and higher selectivity for IDO1 over TDO enzyme.

Premazepam is a benzodiazepine derivative. It is a partial agonist of benzodiazepine receptors and was shown in 1984 to possess both anxiolytic and sedative properties in humans but was never marketed.

U-84569 is a potent inhibitor of human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.

Plomestane is a selective inhibitor of aromatization in human breast tissue and may provide a mechanism for controlling estrogen responsive processes.

Enoximone sulfoxide is a selective phosphodiesterase III (PDE3) inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. Enoximone prevents the degradation of cAMP by PDE, which prolongs signal transduction and its subsequent effects. It is used in patients with congestive heart failure.

VCP-746 is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling. VCP746 reduces hypertrophy in a rat neonatal cardiac myocyte model. VCP746 is a hybrid molecule consisting of an adenosine moiety linked to an adenosine A1 receptor (A1AR) allosteric modulator moiety. At the A1AR, VCP746 mediated cardioprotection in the absence of haemodynamic side effects such as bradycardia.

RMI-12330A is an adenyl cyclase inhibitor.

RMI-18341 is a Testosterone 5 alpha reductase inhibitor.

MDL-101146, (R)- is an effective orally active inhibitor of human neutrophil elastase.

Erythromycin hydrochloride is an inhibitor of protein translation and mammalian mRNA splicing. It inhibits growth of gram negative and gram positiove bacteria.

MDL-104168 is a macrocyclic HIV-protease inhibitor.

MDL-101146, (S)- is an effective orally active inhibitor of human neutrophil elastase.

Piroximone is a phosphodiesterase (PDE) inhibitor.